A Study of MIcrocirculatory Perfusion Alterations in Severe Burn Injury

NCT ID: NCT04500197

Last Updated: 2020-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

21 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-12

Study Completion Date

2020-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of our study is to focus on the efficiency of standard fluid resuscitation in promoting tissue perfusion in severe burns patients (\>15% TBSA). The incidence of microcirculatory perfusion alterations, according to a predefined arbitrary cut off value, in patients with severe burns injury (\>15%TBSA) will be assessed during standard resuscitation in the first 24 hours.

Secondary objectives are to assess differences in microcirculatory perfusion alterations between early (\<12 hours post burn injury) and late standard resuscitation (\>12 hours post burn injury) with addition of albumin to the regime.

And to measure several biomarkers of glycocalyx shedding, oxidative stress and inflammation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale: There are valid concerns that resuscitation in burns shock is inadequate. A tendency to over resuscitate patients seem to exist. Current guidelines were developed 35 years ago and clinical burn resuscitation has not advanced significantly, despite ongoing research. The main goal of resuscitation is achieving organ perfusion and tissue oxygenation. Inadequate fluid resuscitation of severe acute burns may result in hypovolemic shock and death. Excessive fluid resuscitation may result in fluid overload, lung edema, intra-abdominal hypertension, abdominal compartment syndrome and burn depth conversion with increased requirement for escharotomies, fasciotomies and skin grafting. Monitoring of adequacy of resuscitation in burns patients has always been guided by systemic hemodynamic variables (macro circulation) like blood pressure, heart rate, stroke volume and urinary output, being urine output the major indicator of successful resuscitation. Whether these end points are successful in achieving adequate perfusion and oxygen transport to the tissues is unknown and relies on the assumption that there is a hemodynamic coherence between the macro and microcirculation whereby improving the macro circulation causes a parallel improvement in the microcirculation Objective: The main objective of our study is to focus on the efficacy of standard fluid resuscitation in promoting tissue perfusion.

Study design: Single-center, prospective, observational clinical study in the Maasstad Hospital.

Study population: All adult patients who are admitted to the Intensive Care Unit with severe burns over 15%TBSA and resuscitated with the standard resuscitation protocol will be included.

Main study parameters/endpoints: Measurement of sublingual microcirculation with vessel density and flow parameters. Also skin perfusion maps (Laser Speckle Imaging) will be recorded. Blood and urine samples will also be used for measuring glycocalyx shedding products.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

Microcirculation assessment and laser speckle imaging are non-invasive procedures, and there are negligible risks. Blood tests will be used for measuring glycocalyx shedding products, this is an invasive procedure which may increase the risk of contamination, patient discomfort and in some extreme cases blood sample collection may be a burden on patient haemoglobin levels which is prone to decrease in critical patients. Assessment is essential for determining whether action is required to change our existing resuscitation regime for critically ill burned patients. If the results show that the current resuscitation regime is suboptimal, then motivation for changing the existing practice can lead to improved clinical care and a reduction in over- or under resuscitation in the ICU environment with its potential harmful effects.

The risks associated with participation can be considered negligible and the burden can be considered minimal in this observational study. The patients taking part in this study will have no direct benefit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Microcirculation Burns Resuscitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ICU admission with a severe burn injuries of ≥15% TBSA
2. ≥ 18 years of age
3. Receiving standard resuscitation protocol for severe burn injury
4. Post burn time up to a maximum of 24 hours

Exclusion Criteria

1. Informed consent not obtained
2. (suspected) generalised infection
3. Other traumatic injury, which is supposed to generate a systemic inflammatory response eg severe fractures, or other types of shock as a result of massive bleeding
4. Patients unlikely to survive \>24 hours
5. Decision not to initiate treatment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maasstad Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Can Ince, Prof

Role: STUDY_DIRECTOR

Erasmus Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maasstad Hospital

Rotterdam, Zuid Nederland, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

L2015126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.